Search - tctmd.com

Displaying 781 - 800 of 1095

Sort: Relevancy | Date

News Daily News

Uninsured STEMI Patients More Likely to Be Transferred, But What Does It Mean?

May 20, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

May 18, 2016

News Daily News

不同收入水平的急性心肌梗死住院率和死亡率有所减少，但差距仍然存在

May 16, 2016

News Daily News

Se Observan Descensos en las Hospitalizaciones por IAM y Mortalidad en Distintos Niveles de Ingresos Aunque se Mantienen las Disparidades

May 16, 2016

News Daily News

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Yael L. Maxwell

May 13, 2016

News Daily News

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Yael L. Maxwell

May 13, 2016

News Daily News

Mechanical Circulatory Support in High-Risk PCI: A Guide to Which, When, Who, and How

May 05, 2016

Management of Patients ≥ 85 Years of Age With ST-Elevation Myocardial Infarction

Presentation

Management of Patients ≥ 85 Years of Age With ST-Elevation Myocardial Infarction

Presenter: Matias B. Yudi

May 02, 2016

News Daily News

老年急性心梗患者就医等待时间仍然太长

Michael O'Riordan

April 28, 2016

News Daily News

Los Pacientes Ancianos que sufren un IAM Tardan Demasiado en Buscar Asistencia Médica

Michael O'Riordan

April 28, 2016

News Daily News

Elderly Acute MI Patients Still Waiting Too Long to Seek Medical Care

Michael O'Riordan

April 28, 2016

News Industry News

DalCor Randomizes First Patient in the DalGenE Phase 3 Cardiovascular Outcomes Trial

April 26, 2016

News Daily News

低体重指数本身预测急性心梗后生存率不佳

April 21, 2016

News Daily News

Un IMC Bajo Per Se Acarrea una Mala Supervivencia Después de Sufrir un IAM

April 21, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

News Daily News

New Analysis of COGENT Supports PPI Use in Patients on Low-Dose Aspirin

March 23, 2016

News Industry News

Aralez resubmits to FDA New Drug Application for YOSPRALA

March 15, 2016

News Industry News

Victoza® Significantly Reduced the Risk of Major Adverse Cardiovascular Events in the LEADER Trial

March 06, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.